Slingshot Insights | Ceru Overview

CERU Overview

Upcoming Projects (CERU)

Don’t see a project related to the company you care about? Create your own!

Upcoming & Overdue Catalysts (CERU)

Don’t see a catalyst related to the company you care about? Create your own!

Occurred Catalysts (CERU)

Cerulean's Phase 2 Clinical Trial demonstrated no statistically significant difference in median PFS and objective response rate for the CRLX101 and Avastin combination compared to SOC in Relapsed Renal Cell Carcinoma
Ticker: CERU
Occurred on: Aug 17, 2016

Strategic Initiatives (CERU)

Cerulean (CERU) Announces Collaboration Agreement with Novartis (NVS) to Develop Nanoparticle-Drug Conjugate (NDC) Product Candidates
Tickers: CERU, NVS
Announcement Date: Oct 19, 2016